Autism clinical trials at UCSF

3 in progress, 2 open to eligible people

Showing trials for

  • External Trigeminal Nerve Stimulation for Children With ASD + ADHD to Reduce Elevated Symptoms

    open to eligible people ages 7-14

    The goal of this clinical trial is to learn if external trigeminal nerve stimulation (eTNS) works to treat ADHD symptoms in children on the autism spectrum (ASD). It will also learn about the efficacy and tolerability of the eTNS device. The main questions it aims to answer are: - Does eTNS reduce ADHD symptoms? - Does eTNS improve core and associated features of ASD? Participation spans 8-12 weeks and includes: - 4-5 in-person visits - 4 brief virtual check-ins - Nightly use of the eTNS device with a small sticky patch applied to child's forehead - Randomized assignment (those who start with the sham device may try the active device later)

    San Francisco 5391959, California 5332921

  • Brain Development Research Program

    open to all eligible people

    Dr. Elliott Sherr and his collaborators at University of California, San Francisco (UCSF) are studying the genetic causes of disorders of cognition and epilepsy, in particular disorders of brain development that affect the corpus callosum, such as Aicardi syndrome, as well as two additional brain malformations, polymicrogyria and Dandy-Walker malformation. The goal of the investigators' research is to use a better understanding of the underlying genetic causes as a foundation to develop better treatments for these groups of patients.

    San Francisco 5391959, California 5332921

  • CM-AT for the Treatment of Children With Autism

    Sorry, in progress, not accepting new patients

    This is a Phase III, open label extension study evaluating the continued safety and efficacy of CM-AT in pediatric patients with autism with all levels of fecal chymotrypsin.

    San Francisco 5391959, California 5332921 and other locations

Our lead scientists for Autism research studies include .

Last updated: